The museum has suffered from rising costs and lower attendance. The cuts followed those at the Brooklyn Museum, which trimmed ...

Guggenheim Museum in New York announced on Friday that it will lay off 20 employees in an effort to improve its financial ...

Guggenheim Securities, the investment banking arm of Guggenheim Partners, has formed a strategic alliance with Australia’s ...

The Plaza Hotel suite where Frank Lloyd Wright resided during construction of the Guggenheim Museum is up for sale for $18.9 ...

Guggenheim has initiated Metsera at buy saying that the biotech's pipeline of injectable and oral nutrient stimulated hormone ...

Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.

Guggenheim reiterated their buy rating on shares of ProMIS Neurosciences (NASDAQ:PMN – Free Report) in a report issued on Wednesday,Benzinga reports. ProMIS Neurosciences Stock Down 0.3 % ProMIS ...

Guggenheim analyst Michael Morris maintained a Buy rating on Paramount Global Class B (PARA – Research Report) yesterday and set a price target ...

The trial of three men accused in the theft or sale of an 18-carat gold toilet that was a pricey piece of satirical art is ...

The performance artist Marina Abramovic celebrated the announcement of a new cultural center in a private home designed by ...

Guggenheim initiated coverage of Sportradar (SRAD) with a Buy rating and $27 price target Discover the Best Stocks and Maximize Your Portfolio: ...

Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...